References
Bachis A, Mallei A, Cruz MI, Wellstein A, Mocchetti I (2008) Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology 55:1114–1120
Duman RS (1998) Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 44:324–35
Duman R, Monteggia L (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127
Kleindienst A, Meissner S, Eyupoglu IY, Parsch H, Schmidt C, Buchfelder M (2010) Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury. Acta Neurochir Suppl 106:247–250
Neumeister A, Yuan P, Young TA, Omer Bonne O, Luckenbaugh DA, Charney DS, Manji H (2005) Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry 162:805–807
Schroeter M, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig I (2008) Serum markers support disease-specific glial pathology in major depression. J Affect Disord 111:271–280
Sen S, Duman R, Sanacora G (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64:527–532
Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M, Carpio C, Spitzer G, Santarelli L, Scharf B, Hen R, Rosoklija G, Sackeim HA, Dwork AJ (2007) Antidepressant-Induced Neurogenesis in the Hippocampus of Adult Nonhuman Primates. J. Neurosci. 27:4894–4901
Young KM, Merson TD, Sotthibundhu A, Coulson EJ, Barlett PF (2007) p75 Neurotrophin Receptor Expression Defines a Population of BDNF-Responsive Neurogenic Precursor Cells. J. Neurosci. 27:5146–5155
Author information
Authors and Affiliations
Corresponding author
Additional information
Hugo Critchley is supported by the Wellcome Trust.
Rights and permissions
About this article
Cite this article
Whale, R., Beacher, F., Golding, B. et al. The acute effect of tryptophan depletion on serum neurotrophin levels (BDNF, FGF2, and S100B) in healthy subjects. Psychopharmacology 213, 651–652 (2011). https://doi.org/10.1007/s00213-010-1865-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-010-1865-0